Prognostic relevance of the neurological symptom burden in brain metastases from breast cancer
Neurological burden at BM diagnosis independently predicts survival in BC patients. Our findings emphasise incorporating the symptom status in the prognostic evaluation and reassessing BM screening in high-risk patients during prospective clinical trials.
Authors
- Christian Fridolin Singer (ORCID: https://orcid.org/0000-0003-1294-0027)
- Zsuzsanna Bagó-Horváth (ORCID: https://orcid.org/0000-0002-8555-7806)
- Florian Fitzal (ORCID: https://orcid.org/0000-0003-2617-3965)
- Ariane Steindl (ORCID: https://orcid.org/0000-0002-5839-8301)
- Anna Sophie Berghoff (ORCID: https://orcid.org/0000-0001-9379-6797)
- Franziska Eckert (ORCID: https://orcid.org/0000-0002-4742-3962)
- Rupert Bartsch (ORCID: https://orcid.org/0000-0002-4384-6917)
- Johannes A. Hainfellner (ORCID: https://orcid.org/0000-0002-9148-958X)
- Anna Grisold (ORCID: https://orcid.org/0000-0002-5619-4858)
- L. Berchtold
- Matthias Preusser (ORCID: https://orcid.org/0000-0003-3541-2315)
- Georg Widhalm (ORCID: https://orcid.org/0000-0001-6014-0273)
- Ruth Exner (ORCID: https://orcid.org/0000-0002-1168-1310)
- Clara Zach
- Brigitte Gatterbauer (ORCID: https://orcid.org/0000-0002-3346-0236)
- Georg Pfeiler
Institutions
- Statistics Austria (AT)
- Comprehensive Cancer Center Vienna (AT)
- Christian Doppler Laboratory for Thermoelectricity (AT)
- Medical University of Vienna (AT)
Publication Details
- Journal
- British Journal of Cancer
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1038/s41416-025-02967-w
- Citations
- 3
- Primary Topic
- Brain Metastases and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 4.56